companydata.dkcompanydata.dk

UNION therapeutics A/S: Financial statements 2023

CVR: 33963750

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

UNION therapeutics A/S (CVR 33963750) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 2,299,000 and a net result of DKK -169,426,000 compared with DKK -214,304,000 the year before. That is a decrease of 93.3% compared with the year before. The profit margin was -7,369.6%. Equity in the 2023 report amounted to DKK -61,599,000.

Revenue
DKK 2,299,000
Profit/Loss
DKK -169,426,000
Equity
DKK -61,599,000
Total Assets
DKK 120,190,000

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20232.3M--169.4M-61.6M-
202234.4M--214.3M-27.7M-
2021118.9M--56M49.4M26
20200--80.9M-58.4M-
201911.6M--12.9M-38.3B-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

MANJIN ApS registered as owner of UNION therapeutics A/SDec 5, 2023

As of December 5, 2023, MANJIN ApS is registered as an owner of UNION therapeutics A/S with an ownership share of 20%.

VENDLER ApS registered as owner of UNION therapeutics A/SDec 5, 2023

As of December 5, 2023, VENDLER ApS is registered as an owner of UNION therapeutics A/S with an ownership share of 20%.

T&W HOLDING A/S registered as owner of UNION therapeutics A/SJul 13, 2023

As of July 13, 2023, T&W HOLDING A/S is registered as an owner of UNION therapeutics A/S with an ownership share of 5%.

UNION therapeutics A/S: The 2022 annual report is outApr 24, 2023

UNION therapeutics A/S has published its annual report for 2022. Revenue came to DKK 34,393,000, and the net result was DKK -214,304,000.

About UNION therapeutics A/S

UNION therapeutics A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 2011. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named AntibioTx A/S and ANTIBIOTX ApS. The management consists of Kim Domela Kjøller, Morten Otto Alexander Sommer and Rasmus Vendler Toft-Kehler. The board consists of Stig Løkke Pedersen (chair), Andrew John Oakley, Morten Otto Alexander Sommer and Peter Kristensen. The company's owners include MANJIN ApS, VENDLER ApS and T&W HOLDING A/S. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -11,802,644 and a net result of DKK -32,142,051 compared with DKK -98,922,000 the year before. Equity in the 2025 report amounted to DKK -147,650,138.

Source: annual report 2025, Danish Business Authority